Editas Medicine, Inc. (EDIT)
2.46
-0.07
(-2.77%)
USD |
NASDAQ |
May 19, 16:00
2.46
0.00 (0.00%)
Pre-Market: 08:08
Editas Medicine Total Liabilities (Quarterly) : 144.93M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Puma Biotechnology, Inc. | 64.28M |
| Black Diamond Therapeutics, Inc. | 28.62M |
| X4 Pharmaceuticals, Inc. | 101.83M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 149.34M |
| Shareholders Equity (Quarterly) | 4.408M |
| Debt to Equity Ratio | 16.33 |
| Current Ratio | 3.219 |
| Net Debt Paydown Yield | -3.06% |